Log In
Register
Facebook icon
LinkedIn icon
Instagram icon
Regulations
Claims/Labeling
Organic/COSMOS
Safety
SPF/Sun
Regional
Safety
Safety
7 Recent Recalls: Babygenics, Tom's of Maine, Amika, HiBAR and Others
From hair spray and repair cream, to tattoo ink, children's sunscreen, toothpaste and others, several products have been recalled in recent months due to safety hazards and regulatory non-compliance. Following is an overview.
Safety
J&J’s Baby Powder Legal Battle Persists with $10 B Settlement at Stake
Safety
California State Assemblymember Takes Action Against 'Sephora Kids' Trend
Latest
Sponsored
Back to the Roots – Targeting the Root Causes of Skin Aging
We explore the science of skin aging and the power of prevention. Featuring innovative active ingredients, the "Timeless Rituals" formulation concept combines fermentation technology with mindful self-care for healthy, resilient skin.
Regional
EU/UK Cosmetic Legal Brief: 8 INCIs Named CMRs, Kojic Acid/Methyl Salicylate Notices, PFAS — And Simplifying REACH?
Recent regulatory activities around European cosmetics include: 8 INCIs added to the CMR list, kojic acid in Annex III, methyl salicylate's restriction notification, the latest PFAS rulings and a German chemical group's pushback on simplifying REACH.
Actives
Croda Beauty Highlights PFAS-free Peptides, Commits to Complete Portfolio Transition by 2026
"By eliminating substances like TFA (trifluoroacetic acid) from our peptide synthesis processes, we prioritize both consumer safety and sustainability," Croda Beauty explained.
Safety
FDA Proposes MoCRA-mandated Tests to Detect Asbestos in Talc-containing Cosmetics
On Dec. 26, 2024, the FDA proposed test methods by which cosmetic manufacturers would be required by MoCRA to assess talc-containing products for asbestos, along with enforcement provisions.
Safety
Safety Alerts: Drunk Elephant's 'Mix-up,' 285 European Cosmetics with Banned Ingredients, Dynarex Extended Recall
This round-up highlights recent cosmetic safety alerts/recalls. These include: Drunk Elephant's ingredient "mix-up," ECHA's findings that 6% of ~4,500 cosmetics reviewed contained banned ingredients, and Dynarex's recall extension over possible asbestos.
Safety
Two New Reasons to Reexamine PFAS Safety, Exposure: Pregnancy and Sleep
Two recent studies have raised new alarm over PFAS. One found higher levels of PFAS in pregnant women who use cosmetics. The other associated sleep disruption with PFAS in young adults. These findings add to the public outcry over "forever chemicals."
Regional
Fees Increased on U.S. FDA Color Additive Certification; Here's What You'll Pay
"The color certification process for synthetic organic colorants is an important aspect of color additive regulations that is unique to the United States," notes industry expert Kelly Dobos. "This fee had remarkably not been raised in nearly 20 years."
Safety
FDA Warns Consumers: Undisclosed Steroid in Skin-Cap Skin/Scalp Treatment Spray, Do Not Use
Per the agency, testing identified a high-potency glucocorticosteroid in the aerosol spray product that is not disclosed on the label or packaging. As such, consumers are warned not to use the products.
Regional
European Regulatory Update: Cosmetic Ingredient Changes Coming in 2025-2026
This article looks to changes in 2025-2026 to the status of ingredients in the EU and UK. Examples include nanomaterial and UV filter bans/restrictions, limits on actives, labeling formaldehyde-releasing preservatives and allergens, ecodesign and others.
Companies
[video] How Well Do We Know Our Beauty Ingredients? ChemForward, Sephora, Ulta, The Honest Company, Credo Beauty and More Have Some Answers.
Through its Know Better, Do Better (KBDB) Collaborative, in partnership with retailers and ingredient suppliers, Chemforward has released findings aggregating individual reports with the aim to set clear standards for cosmetic ingredient safety.
Safety/Stability
[updated] Could UV Affect Benzene Formation? New Findings in BPO Acne, Rosacea Products
Of some 111 OTC drug products taken from retail shelves and tested at room temperature, 34%, including brands such as Clearasil, CVS Health, La Roche-Posay and Proactiv, exceeded the FDA's conditional benzene limit. The PCPC weighed in on these findings.